Home / Guidelines & Products

Q6(R1) – Revision of the Specifications Guidelines

Guideline number: Q6(R1)

This topic was endorsed by the ICH Assembly in June 2021.

Further to the ICH Management Committee’s endorsement of the Q6(R1) Concept Paper in July 2024, the Q6(R1) Guideline aims to update and modernise simultaneously the ICH Q6A and Q6B guidelines by promoting consistency between ICH Q6A and Q6B and establish general principles in setting specifications for all product modalities; aligning with other relevant ICH guidelines and current approaches; and revising the scope of the guideline to incorporate contemporary modalities. In addition, the Q6(R1) EWG aims to develop complementary training material with relevant examples/case studies.

Endorsed Documents

Ongoing public consultations

No results found.

Q6(R1) Expert Working Group

Rapporteur

Ms. Silmara Cristiane da Silveira AndreoliANVISA, Brazil
Dr. Olivier DiratPhRMA

Regulatory Chair

Dr. Robin LevisFDA, United States

Experts

ANPP, AlgeriaDr. Amel Bensedira
ANVISA, BrazilMs. Camila Filizzola de Andrade Sena
APICMs. Rita Silva
BIODr. Andrew Chang
BIODr. Cecilia Tami
COFEPRIS, MexicoMr. Christian Garnica
EACMr. Peter Hamisi Safari
EC, EuropeDr. Elisabeth Strutzmann
EC, EuropeMr. Mats Welin
EDA, EgyptDr. Rafeek Shokry
EDQMMr. Cristian Sampaolesi
EFPIADr. Yves Bobinnec
EFPIADr. Cristiana Campa
FDA, United StatesDr. Elizabeth Lessey-Morillon
FDA, United StatesDr. Matthew Vera
Health Canada, CanadaDr. Karen Rowlandson
Health Canada, CanadaMr. Robin Zhang
IFPMADr. Zhenming An
IGBADr. Hans-Georg Giesen
IGBADr. Houri Simonian
JFDA, JordanDr. Sawsan Shahin
JPMADr. Takahiro Yamaguchi
MFDS, Republic of KoreaMs. Heejin Lee
MHLW/PMDA, JapanDr. Akiko Ishii-Watabe
MHLW/PMDA, JapanDr. Atsuko Oimura
MHRA, UKDr. Bassel Odeh
NMPA, ChinaMs. Dongchen Jia
PhRMAMr. Allen Callaway
SAHPRA, South AfricaMr. Mphako Brighton Ratlabyana
SFDA, Saudi ArabiaDr. Saeed Al Awadh
Swissmedic, SwitzerlandDr. Ulla Grauschopf
TFDA, Chinese TaipeiDr. Tung-Ju Hsieh
TITCK, TürkiyeMs. Sedef Benli
USPDr. Horacio Pappa

Rapporteur Supporter

Mr. Felipe Oliveira DiasANVISA, Brazil

Alternate

Ms. Beatriz Lilian da Silva Costa SouzaANVISA, Brazil
Dr. Emmanuelle ChartonEDQM
Dr. Xin MaIFPMA
Ms. Manal KhaderJFDA, Jordan
Ms. Soyeong KangMFDS, Republic of Korea
Ms. Lihua XuNMPA, China
Dr. Juliane WinklerSwissmedic, Switzerland
Ms. Elif ŞimşekTITCK, Türkiye
Dr. Kevin CarrickUSP

Related guidelines